ARZMX
Price
$16.22
Change
+$0.18 (+1.12%)
Updated
Jul 9 closing price
Net Assets
1.02B
SSGSX
Price
$52.88
Change
+$0.60 (+1.15%)
Updated
Jul 9 closing price
Net Assets
4.5B
Interact to see
Advertisement

ARZMX vs SSGSX

ARZMX vs SSGSX Comparison Chart in %
View a ticker or compare two or three
VS
ARZMX vs. SSGSX commentary
Jul 11, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARZMX is a Buy and SSGSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SSGSX has more cash in the bank: 4.5B vs. ARZMX (1.02B). SSGSX pays higher dividends than ARZMX: SSGSX (0.51) vs ARZMX (0.38). ARZMX was incepted earlier than SSGSX: ARZMX (9 years) vs SSGSX (27 years). SSGSX (1.23) is less costly to investors than ARZMX (1.00). SSGSX is a more actively managed with annual turnover of: 50.00 vs. ARZMX (42.00). SSGSX has a lower initial minimum investment than ARZMX: SSGSX (2500) vs ARZMX (5000000). SSGSX annual gain was more profitable for investors over the last year : 15.78 vs. ARZMX (-3.05). ARZMX return over 5 years is better than : 2.94 vs. SSGSX (-2.82).
ARZMXSSGSXARZMX / SSGSX
Total Expense Ratio1.001.2381%
Annual Report Gross Expense Ratio1.001.2381%
Fund Existence9 years27 years-
Gain YTD6.36616.98437%
Front LoadN/A6%-
Min. Initial Investment50000002500200,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.02B4.5B23%
Annual Yield % from dividends0.380.5174%
Returns for 1 year-3.0515.78-19%
Returns for 3 years9.8512.4879%
Returns for 5 years2.94-2.82-104%
Returns for 10 yearsN/A40.91-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RLMD6.510.10
+1.56%
Relmada Therapeutics
FOXA53.740.35
+0.66%
Fox Corp
HP32.75-0.25
-0.76%
Helmerich & Payne
TCX10.42-0.22
-2.07%
Tucows
GELS0.54-0.01
-2.66%
Gelteq Ltd